Cervical Lymphadenopathy:

Look For First

Central low attenuation or frank cystic change with irregular enhancing rim—hallmark of metastatic squamous cell carcinoma (SCC) or necrotic disease
Loss of fatty hilum and rounded shape instead of normal reniform (kidney-bean) morphology indicating effacement of normal nodal architecture
Punctate or fine calcification suggesting metastatic papillary or medullary thyroid carcinoma; coarse dense calcification suggesting granulomatous disease or treated malignancy
Nodal matting, infiltrative margins into adjacent fat, or direct invasion of muscle/skin indicating extranodal extension

Key Image Findings

On contrast-enhanced CT: nodal morphology and distribution are more informative than size alone; standard size thresholds (~11 mm jugulodigastric, 10 mm other cervical, 5–6 mm retropharyngeal) are guides rather than rules since micrometastatic nodes can be normal-sized and reactive nodes can enlarge.
Because reactive lymph nodes in the submandibular region may grow to more than 1 cm in size, submandibular nodes are not suggested to be neoplastic until they are more than 1.5 cm in diameter. Keep in mind that enhancement characteristics of lymph nodes are more helpful in determining metastatic involvement than size alone.
Central low attenuation (caseous or necrotic change) with irregular, thick, enhancing rim is highly specific for metastatic SCC; the irregular rim distinguishes tumor necrosis from simple cystic degeneration and is more concerning than homogeneous enhancement.
Well-defined cystic nodes, particularly at level II/III, in association with HPV-related oropharyngeal SCC may be nearly completely fluid-filled; septa, mural tissue, calcification, echogenic foci, or peripheral vascularity favor metastasis over benign cyst.
Punctate or psammomatous calcification (especially with cystic change, echogenic material, or hyperenhancement) strongly suggests papillary thyroid carcinoma; medullary thyroid carcinoma can also present with calcified hypervascular metastases.
Marked or heterogeneous enhancement concentrating in a thick irregular wall, mural nodule, or diffuse pattern suggests hypervascular metastasis (thyroid, RCC, neuroendocrine tumor, Kaposi sarcoma), Castleman disease, or Kikuchi/Kimura disease.
MRI demonstrates necrotic nodes with central T2 hyperintensity and nonenhancement with irregular enhancing solid rim; diffusion restriction is nonspecific and should be interpreted with morphology, enhancement, distribution, and clinical context rather than as a stand-alone finding.
Nodal distribution follows predictable lymphatic drainage: level II/III for oropharynx and nasopharynx (especially cystic HPV-positive lesions), level IV for hypopharynx and thyroid, posterior-triangle nodes (level V) for nasopharynx and granulomatous disease.
Extranodal extension is defined by infiltrative projections into perinodal fat, matting with loss of intervening boundaries, or direct invasion of muscle, skin, salivary tissue, or neurovascular structures; necrosis or capsular thickening alone do not constitute extranodal extension.

Differential Diagnosis

Metastatic papillary or medullary thyroid carcinoma—marked enhancement, punctate/psammomatous calcification, cystic components, and hyperenhancement; scrutinize the thyroid gland and map central (level VI) and lateral (levels II–V) nodes.
HPV-associated oropharyngeal squamous cell carcinoma—well-defined cystic node at level II/III with possible septa or mural enhancement; primary in palatine tonsils or tongue base may be small or radiographically occult; requires focused tonsil/tongue-base evaluation.
Metastatic non-thyroid SCC from head-and-neck primary—central low attenuation with irregular viable rim, little surrounding inflammatory change, and distribution in expected tumor-drainage basin.
Tuberculosis or granulomatous disease (sarcoidosis)—multiple homogeneous or caseous nodes with rim enhancement and matting; TB preserves surrounding fat planes, may show fibrocalcification; sarcoid nodes homogeneous but require thoracic correlation.
Castleman disease (unicentric)—solitary, sharply demarcated, homogeneous, intensely enhancing nodal mass; imaging overlap with hypervascular metastasis is substantial and requires tissue diagnosis; communicate vascularity before biopsy.
Suppurative adenitis or abscess—central low attenuation with rim enhancement and surrounding inflammatory fat stranding, cellulitis, fever, and identifiable infectious source; may require drainage in addition to antimicrobial therapy.

Discussion

Nodal size thresholds are guides, not rules: a small necrotic node remains abnormal even if below threshold; conversely, reactive nodes in viral infection or early inflammation can exceed threshold without malignancy.

Central low attenuation with an irregular enhancing rim is one of the most specific imaging signs of nodal metastasis in patients with a head-and-neck primary, distinguishing it from simple cystic degeneration or benign cyst.

Cystic cervical nodes in adults must not be dismissed as branchial cleft cysts without thorough evaluation; an adult upper-neck cystic mass requires focused tonsil and tongue-base inspection, targeted endoscopy, and HPV testing when metastatic SCC is confirmed.

Calcification is neither intrinsically benign nor malignant; newly identified calcified nodes should not automatically be labeled as healed granulomatous disease—history of treatment, prior imaging, and imaging distribution are essential for interpretation.

Diffusion restriction on MRI is nonspecific and can occur with hypercellular lymphoma, metastatic solid tumor, inflammatory nodes, and proteinaceous/purulent material; it should not be used as a stand-alone discriminator but rather integrated with morphology and clinical context.

Nodal distribution follows lymphatic drainage patterns and guides but does not determine the search for a primary; a left supraclavicular node can drain the thorax, abdomen, and pelvis via the thoracic duct, requiring imaging extension below the clavicles when no head-and-neck source is identified.

Reporting Pearls

In reporting a cervical lymph node, specify exact nodal level and side, shape (oval vs. round), hilum status (preserved vs. effaced fatty hilum), internal architecture (homogeneous, heterogeneous, necrotic, cystic, calcified), enhancement pattern (mild, avid, homogeneous, heterogeneous, rim, or septal), margins (smooth vs. infiltrative), and any features suggesting extranodal extension; avoid vague terms like "possible extracapsular spread" and instead identify the specific morphologic finding (e.g., irregular infiltrative projections, matting, or direct muscle invasion).

Pitfalls

Dismissing a normal-sized node as reactive simply because it does not exceed size threshold; micrometastatic disease, necrotic metastasis, or cystic papillary thyroid carcinoma can present in a small node with suspicious morphology (loss of hilum, calcification, cystic change, or irregular rim).
Treating a cystic neck mass in an adult as a benign branchial cleft cyst without continued evaluation; guidelines specifically advise full diagnostic workup until a diagnosis is established, with particular attention to HPV-related oropharyngeal SCC in cystic level II/III nodes.
Over-relying on diffusion restriction as a discriminator or using it to exclude lymphoma; necrosis does occur in aggressive non-Hodgkin lymphoma and should not be used to exclude lymphoproliferative disease.
Confusing perinodal inflammatory stranding or capsular thickening with extranodal extension; true extranodal extension requires infiltrative nodal margins with projections into fat, matting with loss of boundaries, or direct invasion of contiguous structures like muscle or skin.

Cervical Lymphadenopathy:

Key Images

Secondary Links